Loading clinical trials...

Echinacea Junior vs Vitamin C in Children 4-12 Years Old | Clinical Trials | Clareo Health

COMPLETEDPhase 3NCT02971384

Echinacea Junior vs Vitamin C in Children 4-12 Years Old

Aim of this study is to investigate efficacy and safety of Echinaforce Junior Tablets (250mg) in comparison with Vitamin C tablets in the prevention of acute viral respiratory tract infections.

Lead sponsor: A. Vogel AG•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

WITHDRAWNPhase 3

Azithromycin Plus Hydroxychloroquine for COVID-19 Infection

NCT05026801 · Respiratory Tract Infection Viral

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 4, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment203

Start dateNov 2016

Last updatedMay 4, 2021

Condition

Respiratory Tract Infection Viral

Locations shown

Dr. med. Mercedes Ogal

Brunnen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 4, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions